Results 121 to 130 of about 61,873 (295)

Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders

Movement Disorders Clinical Practice, Volume 12, Issue 12, Page 2106-2110, December 2025.
Charles Palmer, Alexander McClanahan, Federico Rodriguez‐Porcel   +2 more
wiley   +1 more source

اثربخشی ريواستيگمين در کاهش نشانه‌های حرکت‌پريشی ديررس در بيماران مبتلا به اسکيزوفرنيا [PDF]

, 2014
هدف : هدف پژوهش حاضر بررسی اثربخشی داروی ريواستيگمين بر کاهش نشانه‌های حرکت‌پريشی ديررس (ديسکينزی تارديو) در بيماران مبتلا به اسکيزوفرنيای دريافت‌کننده داروهای ضدروان‌پريشی بود.
جهانیان, امیرعباس, رضایی, امید, فدایی, فرید, یراقچی, آزاده   +3 more
core  

New and emerging treatments for symptomatic tardive dyskinesia

Drug Design, Development and Therapy, 2013
The aim of this review is to assess new, emerging, and experimental treatment options for tardive dyskinesia (TD). The methods to obtain relevant studies for review included a MEDLINE search and a review of studies in English, along with checking ...
A. Rana, Zishan M Chaudry, P. Blanchet
semanticscholar   +1 more source

Prevalence and Clinical Correlates of Tardive Dyskinesia in Patients with Chronic Mental Illness in Psychiatry Rehabilitation Centres

Online Journal of Health & Allied Sciences
Tardive Dyskinesia (TD) is a medication induced movement disorder characterised by involuntary athetoid or choreiform movements generally of the tongue, lower face and jaw, and extremities developing in association with the use of a neuroleptic ...
Bhanu Dahiya, Tanisha S Bhat, Ravichandra Karkal, Anil Kakunje   +3 more
doaj  

Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia

Neuropsychiatric Disease and Treatment, 2020
Tadesse Misgana,1 Niguse Yigzaw,2 Getachew Asfaw3 1Department of Psychiatry, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 2Department of Psychiatry, College of Medicine and Health Science, University of Gondar, Gondar ...
Misgana T, Yigzaw N, Asfaw G
doaj  

Genome wide study of tardive dyskinesia in schizophrenia [PDF]

, 2021
Keane Lim, Max Lam, Clement C. Zai, Jenny Tay, Nina Karlsson, Smita N. Deshpande, B.K. Thelma, Norio Ozaki, Toshiya Inada, Kang Sim, Siow‐Ann Chong, Todd Lencz, Jianjun Liu, Jimmy Lee   +13 more
openalex   +1 more source

Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment [PDF]

, 2004
Enrico Lattuada, Roberto Cavallaro, Alessandro Serretti, Cristina Lorenzi, Enrico Smeraldi   +4 more
openalex   +1 more source

Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients [PDF]

, 2003
Hélio Anderson Tonelli, Débora Cristina Tonelli, G.R. Poiani, Maria A.B.F. Vital, Roberto Andreatini   +4 more
openalex   +1 more source

Delayed-onset drug-induced movement disorders

Psychiatry and Clinical Psychopharmacology, 2021
Delayed-onset drug-induced movement disorders (tardive syndromes) remain an important clinical problem. There are several phenomenologically and pharmacologically distinct types of tardive syndromes. The term tardive dyskinesia has been used to refer to
Oya Öztürk, Erhan Kurt, Timuçin Oral
doaj  

Long-Term Effects of Once-Daily Valbenazine in Older and Younger Adults with Tardive Dyskinesia [PDF]

, 2022
Martha Sajatovic, Khody Farahmand, Chirag Shah, Leslie Lundt   +3 more
openalex   +1 more source